IP Library Granted Patent US 11,344,404
Granted Patent B2
US 11,344,404 · App. 16/232,725 · Granted May 31, 2022

Distance dominant intraocular lens

Inventors: Nivedan Tiwari (Irvine, CA); Krishnakumar Venkateswaran (Aliso Viejo, CA); Andrew William Jones (Palm Harbor, FL); Chun Zhan (Oldsmar, FL); Lorenzo Salvatori (Lutz, FL)
Assignee: Bausch & Lomb Incorporated
A61F2/1618A61F2/1654G02C7/041G02C7/06G02C2202/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,344,404
App. No.
16/232,725
Granted
May 31, 2022
Kind
B2
Abstract

An intraocular lens includes a base refractive structure having anterior and posterior surfaces that are shaped for producing a first optical power and a diffractive structure formed in one of the surfaces of the base refractive structure including overlapping first and second diffractive patterns over a common aperture for producing second and third optical powers. The second optical power is an uneven division of the third optical power. The first and second diffractive patterns have respective step heights that are separately varied as a function of radial distance from the optical axis over the common aperture.

Claims (32)

1. An intraocular lens comprising:

a base refractive structure having anterior and posterior surfaces that are shaped for producing a first optical power;

a diffractive structure formed in one of the surfaces of the base refractive structure including overlapping first and second diffractive patterns over a common aperture for producing second and third optical powers;

the second optical power being an uneven division of the third optical power;

wherein, the first and second diffractive patterns convey the first optical power through zero order diffraction for forming a distance focus,

wherein, the first and second diffractive patterns convey the second and third optical powers through a first order diffraction for forming, in combination with the first optical power, respective intermediate and near foci, and

wherein, the first and second diffractive patterns have non-harmonic periodicities so that a second order diffraction through the first diffractive pattern produces a focus that is offset from the near focus formed by the first order diffraction through the second diffractive pattern in combination with the first optical power for extending an effective depth of the near focus.

2. The intraocular lens of claim 1 in which:

the first and second diffractive patterns are centered about an optical axis of the base refractive structure, and

the first and second diffractive patterns have respective step heights that are separately varied as a function of radial distance from the optical axis over the common aperture.

3. The intraocular lens of claim 2 in which the step heights of the second diffractive pattern are varied more than the step heights of the first diffractive pattern as a function of the radial distance from the optical axis.

4. The intraocular lens of claim 2 , in which the step heights of the second diffractive pattern are varied more than the step heights of the first diffractive pattern as a function of the radial distance from the optical axis, and wherein the step heights of the first and second diffractive patterns are configured to be separately varied such that the distance focus will receive an increasing portion of optical energy transmitted through the common aperture as a function of the radial distance from the optical axis, and so that the increasing portion will be derived more from a corresponding decrease in the optical energy received by the near focus than a corresponding decrease in the optical energy received by the intermediate focus.

5. The intraocular lens of claim 2 in which the step heights are varied as functions of their radial distance from the optical axis, and the functions differ over different ranges of the radial distance.

6. The intraocular lens of claim 5 in which the step heights of at least one of the diffraction patterns vary in a non-progressive manner with the radial distance.

7. The intraocular lens of claim 1 , wherein second order diffraction through the first diffractive pattern produces a focus that is offset from the near focus formed by the first order diffraction through the second diffractive pattern by 0.1 D.

8. The intraocular lens of claim 1 , wherein step heights of the first and second diffractive patterns are separately varied as a function of radial distance, and wherein two different apodization functions are applied over different radial distances from the optical axis.

9. An intraocular lens comprising:

a base refractive structure having anterior and posterior surfaces that are shaped for producing a first optical power that directs incident light through a distance focus;

a diffractive structure formed in one of the surfaces of the base refractive structure over a common aperture for producing second and third optical powers that in combination with the first optical power direct incident light through respective intermediate and near foci;

the diffractive structure including a first diffractive pattern for producing the second optical power through a first order diffraction;

the diffractive structure including a second diffractive pattern for producing the third optical power through a first order diffraction; and

the first and second diffraction patterns being superimposed over the common aperture and having non-harmonic periodicities so that a second order diffraction through the first diffractive pattern produces a focus that is offset from the near focus formed by the first order diffraction through the second diffractive pattern in combination with the first optical power for extending an effective depth of the near focus.

10. The intraocular lens of claim 9 in which:

the diffractive structure is centered about an optical axis of the base refractive structure,

the step heights of the first and second diffractive patterns are configured to be separately varied such that the distance focus will receive an increasing portion of optical energy transmitted through the common aperture as a function of radial distance from the optical axis, and

so that the increasing portion of the optical energy will be derived more from a corresponding decrease in the optical energy received by the near focus than a corresponding decrease in the optical energy received by the intermediate focus.

11. The intraocular lens of claim 10 in which:

the first and second diffractive patterns have step heights, and

the step heights of the second diffractive pattern are varied more than the step heights of the first diffractive pattern as a function of the radial distance from the optical axis.

12. The intraocular lens of claim 11 in which the step heights are varied as functions of their radial distance from the optical axis, and the functions differ over different ranges of the radial distance.

13. The intraocular lens of claim 12 in which the step heights of at least one of the diffraction patterns vary in a non-progressive manner with the radial distance.

14. The intraocular lens of claim 9 in which the second optical power contributed by the first diffractive pattern is approximately 1.6 diopters and the third optical power contributed by the second diffractive pattern is approximately 3.1 diopters.

Assignments (18)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
PATENT SECURITY AGREEMENT Recorded Oct 4, 2023
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 065120/0086 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048715/0432) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061849/0512 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048556/0758) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 048715/0406) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061775/0290 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 27, 2019
From: BAUSCH & LOMB INCORPORATED; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; SOLTA MEDICAL, INC.; HUMAX PHARMACEUTICAL S.A.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048715/0432 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 27, 2019
From: BAUSCH & LOMB INCORPORATED; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; SOLTA MEDICAL, INC.; HUMAX PHARMACEUTICAL S.A.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 048715/0406 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2018
From: TIWARI, NIVEDAN; VENKATESWARAN, KRISHNAKUMAR; JONES, ANDREW WILLIAM; ZHAN, CHUN; SALVATORI, LORENZO
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 047984/0470 →
Continuity (2)
Provisional Application 62633661 · Feb 22, 2018
Related Publication 20190254810A1 · Aug 22, 2019
Cited By (1)
US 12,433,740